A scoring algorithm distinguishes drug-induced autoimmune-like hepatitis from idiopathic autoimmune hepatitis, suggesting important diagnostic implications.
A scoring algorithm that incorporates specific liver biopsy findings, HAI, and liver biochemistry profiles effectively distinguishes DI-ALH from iAIH.
No takes yet. Share an insight, caveat, or question.
Dhingra et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: